Most practitioners initiate patients at 1 mL weekly during the first 4 to 8 weeks of GLP-1 therapy, then reassess tolerability and energy levels before advancing to 2 mL or increased frequency
This suggests that in parts of China (like Hainans special medical zone), bremelanotide may be accessible to patients on a trial or early-access basis
This shift is likely to drive higher demand for regular monitoring of glucose, lipids, liver, kidney, and cardiac parameters. Ameera Shah, Chairperson, Metropolis Healthcare | Q1 FY26 Dr Lal PathLabs is less convinced at least so far: Patient volume growth is partly a factor of the improved collection and lab network we have put in place
more 3.7 | 1,025 Hot Deal 78% 499 108 Buy at 33 Apply offers for maximum savings Apply offers for maximum savings
Nature 599 , 102107 (2021)